Mary S McCabe
Affiliation: Memorial Sloan-Kettering Cancer Center
- Survivorship care: models and programsMary S McCabe
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Semin Oncol Nurs 24:202-7. 2008..To review models of care for adult cancer survivors and the challenges in program development...
- Survivorship programs and care planningMary S McCabe
Cancer Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Cancer 119:2179-86. 2013..A review of research focused on the evaluation of definitions and outcomes is provided along with a discussion of important areas requiring future research...
- Clinical update: survivorship care--models and programsMary S McCabe
Cancer Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Semin Oncol Nurs 28:e1-8. 2012..To provide a clinical update of models of care for adult cancer survivors and the challenges in program development...
- Looking beyond survival survivorship care is critical to the future of oncologyMary S McCabe
Cancer Survivorship Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Oncology (Williston Park) 21:398. 2007
- Models for delivering survivorship careKevin C Oeffinger
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:5117-24. 2006..The aims of this article are to provide a rationale for survivor health care and to articulate a taxonomy of models of survivor care that is applicable to both community practices and academic institutions...
- Melanoma survivorship: research opportunitiesSusan A Oliveria
Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, 160 East 53rd Street, New York, NY 10022, USA
J Cancer Surviv 1:87-97. 2007..Here, we outline the important research opportunities related to the study of melanoma survivorship and summarize the paucity of literature currently available...
- Ethics guidelines for research with the recently deadRebecca D Pentz
Winship Cancer Institute, Emory University, 1365 C Clifton Road NE, C30008, Atlanta, Georgia 30322, USA
Nat Med 11:1145-9. 2005....
- Risks and benefits of phase 1 oncology trials, 1991 through 2002Elizabeth Horstmann
Department of Clinical Bioethics, Warren G Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892 1156, USA
N Engl J Med 352:895-904. 2005..Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in current phase 1 oncology trials...
- Living beyond cancer: survivorship is more than survivingMary S McCabe
Nat Clin Pract Urol 4:575. 2007
- Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperativesBarry D Anderson
National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD 20892 7436, USA
J Clin Oncol 22:4846-50. 2004....
- Progress against cancer: the National Cancer Institute's roleMary S McCabe
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
J Cancer Educ 18:161-3. 2003
- Incremental treatment costs in national cancer institute-sponsored clinical trialsDana P Goldman
RAND Health, 1700 Main St, Santa Monica, CA 90407 2138, USA
JAMA 289:2970-7. 2003..Concern about additional costs for direct patient care impedes efforts to enroll patients in clinical trials. But generalizable evidence substantiating these concerns is lacking...